Insider Transactions in Q2 2024 at Longeveron Inc. (LGVN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2024
|
Khoso Baluch |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.83%
|
$125
$1.06 P/Share
|
|
Jun 03
2024
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-0.23%
|
$325
$1.04 P/Share
|
|
May 10
2024
|
Richard N Kender |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
$16,000
$1.46 P/Share
|
|
May 02
2024
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308
-14.81%
|
$616
$2.83 P/Share
|
|
May 02
2024
|
Lisa Locklear Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-11.13%
|
$820
$2.83 P/Share
|
|
Apr 11
2024
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
31,915
+13.27%
|
$63,830
$2.35 P/Share
|
|
Apr 11
2024
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,638
+35.16%
|
$21,276
$2.35 P/Share
|
|
Apr 11
2024
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
42,553
+6.3%
|
$85,106
$2.35 P/Share
|
|
Apr 10
2024
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
106,383
+37.59%
|
$212,766
$2.35 P/Share
|
|
Apr 10
2024
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
106,383
+15.26%
|
$212,766
$2.35 P/Share
|